Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
DCGOthis companyDocGo Inc.	$0.25	-0.48×	0.6×	0.27×	-0.38×	-3393.8%	30.7%	-27.7%	-56.6%	-126.7%	-55.8%	31.1%	0.2×	0.13×	-87.92×	2.26×	0.0%	3	-2.61	3	B
COYACoya Therapeutics, Inc.	$3.04	-4.57×	2.26×	12.21×	-2.37×	45.7%	99.7%	-255.0%	-267.1%	-49.3%	-46.0%	-11.1%	0×	2.21×	0×	8.5×	0.0%	3	8.76	1	D+
IMMXImmix Biopharma, Inc.	$8.63	-5.88×	1.84×	0×	-2.69×	-63.4%	0.0%	0.0%	0.0%	-31.4%	-31.6%	-14.3%	0.01×	3.14×	0×	10.01×	0.0%	2	35.26	2	C+
MBOTMicrobot Medical Inc.	$1.14	-6.9×	1.18×	0×	-6.76×	-93.0%	0.0%	0.0%	0.0%	-16.9%	-18.8%	-14.3%	0.01×	0.23×	0×	23.33×	0.0%	2	8.03	2	C+
MGNXMacroGenics, Inc.	$2.44	-1.36×	1.83×	0.68×	-2.54×	-2714.5%	71.1%	-48.7%	-49.9%	-134.2%	-33.0%	-81.6%	1.92×	-0.83×	-8.56×	5.1×	0.0%	1	-4.43	1	D+
NSPRInspireMD, Inc.	$0.68	-2.34×	2.37×	14.56×	-2.59×	-939.0%	29.5%	-547.0%	-543.3%	-88.4%	-82.2%	-28.1%	0.06×	0.12×	0×	5.74×	0.0%	2	-11.16	2	C+
Peer median	—	-4.57×	1.84×	0.68×	-2.59×	-93.0%	29.5%	-48.7%	-49.9%	-49.3%	-33.0%	-14.3%	0.01×	0.23×	0×	8.5×	0.0%	2	8.03	2	—